Literature DB >> 1576356

Urinary excretion of retinol-binding protein in type 1 (insulin-dependent) diabetic patients with microalbuminuria and clinical diabetic nephropathy.

P Pontuch1, T Jensen, T Deckert, P Ondrejka, M Mikulecky.   

Abstract

The urinary excretion of retinol-binding protein (RBP) was studied in 101 insulin-dependent diabetic patients allocated to three groups according to 24-h urinary albumin excretion rate (UAE) (median of three urine collections): group 1 (n = 45), normal UAE less than 30 mg/24 h; group 2 (n = 27), microalbuminuria (UAE 30-300 mg/24 h); and group 3 (n = 29), clinical diabetic nephropathy (UAE greater than 300 mg/24 h). We used 23 healthy subjects as controls. Fractional clearance of RBP (FC-RBP) and its 24-h urinary excretion rate (URBP) were higher in each diabetic group than in healthy subjects, the highest values being found in group 3. Groups 1 and 2 did not differ in URBP and FC-RBP. There was a correlation between FC-RBP and haemoglobin A1c in both the total diabetic cohort (P less than 0.001) and in diabetic patients in groups 1 and 2 with a glomerular filtration rate of more than 90 ml/min (P less than 0.05). No correlation was found between FC-RBP and UAE and/or duration of diabetes in any of the diabetic groups. We conclude that the increased urinary excretion of RBP, indicating proximal tubular dysfunction, is already present in normoalbuminuric insulin-dependent diabetic patients and correlates with metabolic control. Further deterioration in proximal tubular function was not observed in microalbuminuric patients, but is a late event in clinical diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576356     DOI: 10.1007/bf00779000

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  34 in total

1.  The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics.

Authors:  H H Parving; I Noer; T Deckert; P E Evrin; S L Nielsen; J Lyngsoe; C E Mogensen; M Rorth; P A Svendsen; J Trap-Jensen; N A Lassen
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

2.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

3.  Creatinine assay by a reaction-kinetic principle.

Authors:  K Larsen
Journal:  Clin Chim Acta       Date:  1972-10       Impact factor: 3.786

4.  Beta 2 2 microglobulin in urine: not suitable for assessing renal tubular function.

Authors:  M D Bastable
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

5.  Urinary proteins and red blood cell membrane negative charges in diabetes mellitus.

Authors:  A Bernard; A O Amor; J Goemare-Vanneste; J L Antoine; R Lauwerys; I Colin; B Vandeleene; A Lambert
Journal:  Clin Chim Acta       Date:  1990-10-15       Impact factor: 3.786

6.  Normal urinary albumin excretion in recently diagnosed type 1 diabetic patients.

Authors:  B Lind; T Jensen; B Feldt-Rasmussen; T Deckert
Journal:  Diabet Med       Date:  1989-11       Impact factor: 4.359

7.  Incipient nephropathy in type 1 (insulin-dependent) diabetes.

Authors:  E R Mathiesen; B Oxenbøll; K Johansen; P A Svendsen; T Deckert
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

8.  Retinol binding protein as a small molecular weight marker of renal tubular function in diabetes mellitus.

Authors:  D J Rowe; F Anthony; A Polak; K Shaw; C D Ward; G F Watts
Journal:  Ann Clin Biochem       Date:  1987-09       Impact factor: 2.057

9.  Glomerular permeability to neutral and anionic dextrans in experimental diabetes.

Authors:  L D Michels; M Davidman; W F Keane
Journal:  Kidney Int       Date:  1982-05       Impact factor: 10.612

Review 10.  The retinol-binding protein.

Authors:  L Rask; H Anundi; J Böhme; U Eriksson; A Fredriksson; S F Nilsson; H Ronne; A Vahlquist; P A Peterson
Journal:  Scand J Clin Lab Invest Suppl       Date:  1980
View more
  5 in total

1.  Urine AQP5 is a potential novel biomarker of diabetic nephropathy.

Authors:  Yiyang Lu; Lihe Chen; Binhong Zhao; Zhou Xiao; Ting Meng; Qiaoling Zhou; Wenzheng Zhang
Journal:  J Diabetes Complications       Date:  2016-03-29       Impact factor: 2.852

2.  Proximal tubule cell hypothesis for cardiorenal syndrome in diabetes.

Authors:  Akihiko Saito; Ryohei Kaseda; Michihiro Hosojima; Hiroyoshi Sato
Journal:  Int J Nephrol       Date:  2010-12-09

3.  Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes.

Authors:  Shinya Ogasawara; Michihiro Hosojima; Ryohei Kaseda; Hideyuki Kabasawa; Keiko Yamamoto-Kabasawa; Hiroyuki Kurosawa; Hiroyoshi Sato; Noriaki Iino; Tetsuro Takeda; Yoshiki Suzuki; Ichiei Narita; Kunihiro Yamagata; Yasuhiko Tomino; Fumitake Gejyo; Yoshiaki Hirayama; Sakari Sekine; Akihiko Saito
Journal:  Diabetes Care       Date:  2012-03-12       Impact factor: 19.112

Review 4.  Molecular mechanisms of receptor-mediated endocytosis in the renal proximal tubular epithelium.

Authors:  Akihiko Saito; Hiroyoshi Sato; Noriaki Iino; Tetsuro Takeda
Journal:  J Biomed Biotechnol       Date:  2010

5.  Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.

Authors:  Seiji Kobayashi; Hoichi Amano; Hiroyuki Terawaki; Makoto Ogura; Yoshindo Kawaguchi; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2019-08-06       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.